Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population

H. Whittaker (London, United Kingdom), J. Pimenta (Uxbridge , United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom)

Source: International Congress 2019 – Powerful cohort studies with/without lung function
Session: Powerful cohort studies with/without lung function
Session type: Oral Presentation
Number: 1588
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Whittaker (London, United Kingdom), J. Pimenta (Uxbridge , United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom). Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population. 1588

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019


Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019


Are normal lung sounds on aucultation associated with FEVI and FVC volume changes in Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial lung disease (ILD)?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Health care resource utilization (HCRU) in early and late diagnosed Chronic Obstructive Pulmonary Disease (COPD) patients in UK primary care
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019


Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013



Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014


Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017

Unemployment in chronic airflow obstruction (CAO) around the world: Results from the Burden of Obstructive Lung Disease (BOLD) study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003